| Primary |
| Constipation |
47.9% |
| Colonoscopy |
9.9% |
| Hypertension |
7.0% |
| Bowel Preparation |
4.6% |
| Blood Cholesterol Increased |
3.9% |
| Diabetes Mellitus |
3.9% |
| Preoperative Care |
3.2% |
| Gastric Disorder |
2.5% |
| Asthma |
2.1% |
| Cardiac Disorder |
1.8% |
| Faeces Hard |
1.8% |
| Hypothyroidism |
1.8% |
| Prophylaxis |
1.8% |
| Depression |
1.4% |
| Pain |
1.4% |
| Anticoagulant Therapy |
1.1% |
| Arthritis |
1.1% |
| Blood Pressure Increased |
1.1% |
| Contraception |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
|
| Vomiting |
19.6% |
| Constipation |
9.3% |
| Rectal Haemorrhage |
9.3% |
| Overdose |
7.5% |
| Incorrect Route Of Drug Administration |
5.6% |
| Drug Abuse |
4.7% |
| Drug Ineffective |
4.7% |
| Diarrhoea |
3.7% |
| Muscle Spasms |
3.7% |
| Nausea |
3.7% |
| Syncope |
3.7% |
| Abdominal Pain Upper |
2.8% |
| Faeces Discoloured |
2.8% |
| Feeling Abnormal |
2.8% |
| Gastrointestinal Motility Disorder |
2.8% |
| Loss Of Consciousness |
2.8% |
| Malaise |
2.8% |
| Pancreatitis |
2.8% |
| Tooth Loss |
2.8% |
| Abdominal Pain |
1.9% |
|
| Secondary |
| Constipation |
18.2% |
| Colonoscopy |
11.6% |
| Product Used For Unknown Indication |
9.2% |
| Electrolyte Substitution Therapy |
9.0% |
| Pain |
5.6% |
| Hypertension |
5.4% |
| Stupor |
5.4% |
| Arthritis |
5.0% |
| Drug Use For Unknown Indication |
4.2% |
| Foetal Exposure During Pregnancy |
3.2% |
| Thrombosis Prophylaxis |
3.0% |
| Depression |
2.8% |
| Restlessness |
2.8% |
| Accidental Exposure |
2.4% |
| Asthma |
2.2% |
| Gastric Disorder |
2.2% |
| Hypothyroidism |
2.2% |
| Atrial Fibrillation |
2.0% |
| Diabetes Mellitus |
2.0% |
| Hyperglycaemia |
1.6% |
|
| Vomiting |
17.3% |
| Constipation |
9.9% |
| Toxic Epidermal Necrolysis |
7.4% |
| Renal Failure Acute |
6.2% |
| Drug Ineffective |
4.9% |
| Overdose |
4.9% |
| Thyroid Disorder |
4.9% |
| Diarrhoea |
3.7% |
| Hyponatraemia |
3.7% |
| Lung Neoplasm Malignant |
3.7% |
| Nausea |
3.7% |
| Pain |
3.7% |
| Renal Failure Chronic |
3.7% |
| Speech Disorder |
3.7% |
| Stevens-johnson Syndrome |
3.7% |
| Transaminases Increased |
3.7% |
| White Blood Cell Count Decreased |
3.7% |
| Arthralgia |
2.5% |
| Bladder Prolapse |
2.5% |
| Drug Abuse |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.1% |
| Drug Use For Unknown Indication |
21.7% |
| Constipation |
8.2% |
| Pain |
7.4% |
| Hypertension |
4.1% |
| Multiple Myeloma |
3.1% |
| Prophylaxis |
2.9% |
| Nausea |
2.2% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Non-small Cell Lung Cancer |
1.9% |
| Anxiety |
1.7% |
| Multiple Sclerosis |
1.6% |
| Depression |
1.6% |
| Insomnia |
1.5% |
| Adverse Event |
1.5% |
| Osteoporosis |
1.4% |
| Rheumatoid Arthritis |
1.1% |
| Diabetes Mellitus |
1.0% |
| Asthma |
0.9% |
| Atrial Fibrillation |
0.9% |
|
| Vomiting |
18.8% |
| Weight Decreased |
12.7% |
| Urinary Tract Infection |
7.9% |
| Death |
7.5% |
| Pneumonia |
5.3% |
| Renal Failure |
4.6% |
| Pulmonary Embolism |
4.5% |
| Sepsis |
4.5% |
| Wheezing |
4.0% |
| Thrombocytopenia |
3.6% |
| Nausea |
3.2% |
| Pyrexia |
3.2% |
| White Blood Cell Count Decreased |
3.0% |
| Pain |
2.7% |
| Renal Failure Acute |
2.6% |
| Syncope |
2.6% |
| Weight Increased |
2.6% |
| Tachycardia |
2.3% |
| Headache |
2.2% |
| Respiratory Failure |
2.2% |
|
| Interacting |
| Constipation |
66.7% |
| Schizophrenia |
16.7% |
| Tremor |
16.7% |
|
| Drug Interaction |
50.0% |
| Tremor |
50.0% |
|
